Comparison of Record in VERITON Camera to the Anger Camera Procedure in Patients Treated by 131-iodine

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

77 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-12-26

Study Completion Date

2025-04-26

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to show that the SPECT/CT whole body recording procedure lasting less than or equal to 30 minutes in a VERITON-CT™ camera, can be substituted for the classic procedure, giving at least equivalent information in searches for primary or metastatic neoplastic lesions.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Investigating National Solutions for Personalised Iodine-131 Radiation Exposure

NCT04391244

Differentiated Thyroid Cancer

UNKNOWN

Multimodality- Adapted Dose Modification in Head and Neck Cancer Radiation Therapy

NCT04933357

Head and Neck Cancer

UNKNOWN PHASE2/PHASE3

SBRT + Immunomodulating Systemic Therapy for Inoperable, Recurrent H&N

NCT03402737

Head and Neck Neoplasm

TERMINATED NA

Optimising Molecular Radionuclide Therapy

NCT04922801

Neuroendocrine Tumors Hyperthyroidism Thyroid Cancer +1 more

COMPLETED

Clinical Evaluation of a Laser Heated, Fiberoptic-Coupled Radiation Dose Verification System

NCT00026871

Neoplasm

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with thyroid cancer treated with iodine 131 will receive an iodine 131 activity of between 1100 and 3700 MBq delivered as a capsule orally to eliminate the remaining thyroid tissue. Hormone replacement therapy (HRT) is then started to correct the hypothyroidism.

3 days later, a 2D whole body recording will be associated with complementary Single Photonic Emission Computed Tomography CT scans (SPECT/CT). It enables visualising the fixation of iodine 131, provides information on the thyroid remnants left in place during surgical thyroidectomy and to carry out an extension assessment by visualizing the possible presence of metastases fixing iodine at the level of the regional lymph nodes or many distant sites, in particular, lung and bone.

In VERICATH study, the hypothesis is that this classic procedure could be advantageously replaced by a single full-body SPECT/CT recording of a limited duration (≤ 30 minutes), obtained with a camera state-of-the-art semiconductor device called the VERITON-CT™ (Spectrum Dynamics Medical) camera.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Device

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Patients received Iode 131 for thyroid cancer and 72 hours after taking iodine capsule,

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Person suffering from thyroid cancer and treated by iodine 131 (1100 MBq or 3700 MBq)

The study will be offered to patients suffering from thyroid cancer and treated by iodine 131 (1100 MBq or 3700 MBq). When they come in nuclear medicine to have the iodine scan in Anger's camera, if they signed the consent, they will the SPECT/CT whole body in VERITON-CT camera

Group Type EXPERIMENTAL

A SPECT-CT whole body is added in VERITON-CT camera

Intervention Type OTHER

A SPECT-CT whole body in VERITON-CT camera is added after the conventional procedure recorded in Anger camera

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

A SPECT-CT whole body is added in VERITON-CT camera

A SPECT-CT whole body in VERITON-CT camera is added after the conventional procedure recorded in Anger camera

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients over the age of 18, who have understood and signed the informed consent form.
2. Person suffering from thyroid cancer and for whom the multidisciplinary meeting has validated a treatment by iodine 131 (1100 MBq or 3700 MBq).
3. Person with no contraindication to carrying out the examination.
4. Person affiliated to a social security scheme.

Exclusion Criteria

1. Person with a known allergy to one of the components of the radiopharmaceutical (Iodine 131 capsule).
2. Pregnant woman or woman of childbearing age and without suitable contraceptive means, or breastfeeding mother.
3. Person whose medical condition is unstable and/or unable to remain still in the supine position during recordings.
4. Person deprived of liberty by a judicial or administrative decision.
5. Person of full age subject to a measure of legal protection (guardianship, curators, safeguard of justice).
6. Adult person unable to express his consent and who is not the subject of a legal protection measure.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No